Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANGEL-DRUG2: Tirofiban in Acute Ischemic Stroke
NCT07290751Phase 4Recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Nov 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tirofiban in ischemic stroke, sponsored by Beijing An Zhen Hospital. Started Nov 2025; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07290751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07290751.